nystatin-a1 and Sjogren-s-Syndrome

nystatin-a1 has been researched along with Sjogren-s-Syndrome* in 4 studies

Reviews

1 review(s) available for nystatin-a1 and Sjogren-s-Syndrome

ArticleYear
Evaluation, differential diagnosis, and treatment of xerostomia.
    The Journal of rheumatology. Supplement, 2000, Volume: 61

    The salivary component of Sjögren's syndrome (SS) is defined as xerostomia (dry mouth). However, xerostomia is a common symptom associated with quantitative and qualitative changes in saliva, which are generally referred to as salivary hypofunction. This can be caused by various systemic diseases (including SS), anticholinergic effects of many drugs, psychological conditions, and physiological changes. Chronic salivary hypofunction is clinically significant because it can cause oral dysfunction, dental destruction, and mucosal infection. Evaluating patients complaining of xerostomia requires particular attention to their current medications and physical examination of the major salivary glands, teeth, and oral mucosa. Based on that information and the differential diagnosis of salivary hypofunction, appropriate tests can then be selected to develop a final diagnosis. Effective treatment of patients with chronic salivary hypofunction requires a combination of: (1) ongoing dental decay prevention and treatment supervised by their dentist; (2) salivary flow stimulation; (3) recognition and treatment of chronic oral candidiasis; (4) selective use of saliva substitutes; and (5) prescription drug review.

    Topics: Antifungal Agents; Candidiasis, Oral; Diagnosis, Differential; Humans; Nystatin; Sjogren's Syndrome; Xerostomia

2000

Other Studies

3 other study(ies) available for nystatin-a1 and Sjogren-s-Syndrome

ArticleYear
[Oral candidiasis in Sjögren's syndrome: prevalence, clinical features and treatment].
    Hua xi kou qiang yi xue za zhi = Huaxi kouqiang yixue zazhi = West China journal of stomatology, 1997, Volume: 15, Issue:3

    The clinical feature of 20 cases with oral candidiasis in Sjögren's syndrome (SS) were reported, and the treatment effect by topical nystatin smearing, 2% sodium bicarbonate solution rinsing, and transfer factor injecting for about 2 months were analysed. The results showed that the diagnostic criterion of oral candidiasis in SS included two aspects: the SS changes confirmed by labial gland biopsy and candidal hyphae and spores found in a smear. The results indicated that the comprehensive treatments were proved to be effective for oral candidiasis in SS.

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Candidiasis, Oral; China; Female; Humans; Male; Middle Aged; Nystatin; Prevalence; Sjogren's Syndrome; Transfer Factor

1997
Oral infections with Candida albicans.
    Scottish medical journal, 1973, Volume: 18, Issue:6

    Topics: Amphotericin B; Biopsy; Candida albicans; Candidiasis, Oral; Cheilitis; Diabetes Complications; Endocrine System Diseases; Fluorescent Antibody Technique; Humans; Immunity, Cellular; Immunologic Deficiency Syndromes; Leukoplakia, Oral; Metabolic Diseases; Nutrition Disorders; Nystatin; Sjogren's Syndrome; Stomatitis, Denture

1973
Management of chronic corneal ulcers.
    Southern medical journal, 1969, Volume: 62, Issue:10

    Topics: Amphotericin B; Chronic Disease; Contact Lenses; Corneal Transplantation; Corneal Ulcer; Epithelium; Female; Humans; Idoxuridine; Keratitis, Dendritic; Keratoconjunctivitis; Male; Middle Aged; Mycoses; Nystatin; Sjogren's Syndrome; Transplantation, Homologous

1969